4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-21-019458
EVP R&D, Chief Medical Officer gave up 368 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-06-07 | Option exercise | +1,250 | 1,250 | D: show line 1 in the form | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-06-07 | Shares withheld for taxes | −368 | $23.50 | $8,648 | 882 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-06-07 | Option exercise · Restricted Stock Unit Award | −1,250 | 0 | D: show line 3 in the form |
Loading xslF345X03/form4.xml…